Blogs & Articles

LATEST ARTICLE

China issues 2021 national reimbursement drugs list, three key trends…

China published its annual update to the national reimbursement drug list (NRDL) on 3rd December, which will be implemented from 1st January 2022. A total of seventy-four drugs entered the NRDL and eleven were removed. Sixty-seven (91%) of the drugs that were added are novel therapies reimbursed for the first time in China. Price negotiation with the…